中文
|
English
Home
|
Help
|
Contact
Return
ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy.
10.3393/ac.2015.31.3.81
Author:
Moo Jun BAEK
1
Author Information
1. Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea. ssurge@sch.ac.kr
Publication Type:
Editorial
MeSH:
Chemotherapy, Adjuvant*; Colonic Neoplasms*; Humans; Prognosis*
From:
Annals of Coloproctology 2015;31(3):81-81
Country
Republic of Korea
Language:
English
Abstract:
No abstract available.